1. Allerheiligen S, Johnson R, Hatcher B (1994) Gemcitabine pharmakokinetics ara influenced by gender, body surface area, and duration of infusion. Proc Am Soc Clin Oncol 13: 136
2. Balducci L, Corcoran MB (2000) Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin North Am 14: 193–212
3. Begg CB, Carbone PP (1983) Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 52: 1986–1992
4. Beretta GD, Michetti G, Belometti MO et al. (2000) Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer. Br J Cancer 83: 573–576
5. Bokemeyer C, Perry MC (1999a) Hepatotoxizität. In: Schmoll HJ, Höffken K, Possinger K (Hrsg) Kompendium internistische Onkologie. Springer, Berlin Heidelberg New Yo